Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Erythema
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Case Reports in Oncology
Case Rep Oncol (2022) 15 (1): 376–381.
Published Online: 31 March 2022
... decreased markedly after starting entrectinib (600 mg/day). After 2 weeks of entrectinib treatment, the patient developed generalized erythema and entrectinib was withdrawn for 1 week, following which erythema improved and entrectinib was resumed (at 600 mg/day) without relapse. After this, the patient...
Journal Articles
Subject Area:
Oncology
Kei Takenaka, Takeshi Sugimoto, Kohei Kawamura, Takeshi Fukumoto, Kenichiro Onuma, Takuya Naito, Masahiro Oka
Journal:
Case Reports in Oncology
Case Rep Oncol (2022) 14 (3): 1315–1322.
Published Online: 16 September 2021
... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Erythema Fever Helicobacter...